Effects of vascular endothelial growth factor in ischemic stroke

被引:158
作者
Ma, Yihui [2 ]
Zechariah, Anil [1 ]
Qu, Yan [2 ]
Hermann, Dirk M. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, D-45122 Essen, Germany
[2] Fourth Mil Med Univ, Xijing Hosp, Inst Neurosurg, Xian 710032, Peoples R China
关键词
VEGF; stroke; angiogenesis; neurogenesis; neuroprotection; FOCAL CEREBRAL-ISCHEMIA; AMYOTROPHIC-LATERAL-SCLEROSIS; BRAIN-BARRIER PERMEABILITY; FACTOR GENE-EXPRESSION; RAT-BRAIN; FACTOR VEGF; IN-VITRO; SIGNAL-TRANSDUCTION; SUBVENTRICULAR ZONE; FUNCTIONAL RECOVERY;
D O I
10.1002/jnr.23088
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Vascular endothelial growth factor (VEGF) is a pleiotropic growth factor that is crucially involved in neurovascular remodeling in the ischemic brain. VEGF promotes angiogenesis, protects ischemic neurons from injury, has potent anti-inflammatory actions, and promotes brain plasticity, in addition to enhancing the recruitment and proliferation of neural precursor cells. These broad actions make VEGF interesting as a model molecule that allows understanding endogenous responses of the brain to injuries. However, several studies indicate that the route and timing of VEGF administration are crucial for the effects of VEGF on ischemic brain tissue. Hence, systemic VEGF delivery in the very acute stroke phase may exacerbate brain damage because of the promotion of bloodbrain barrier breakdown that inevitably accompanies vascular growth. Future studies aimed at the promotion of neurovascular remodeling in ischemic stroke should carefully take into consideration pleiotropic actions of angiogenic growth factors beyond vascular growth. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1873 / 1882
页数:10
相关论文
共 102 条
[1]
Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats [J].
Abumiya, T ;
Yokota, C ;
Kuge, Y ;
Minematsu, K .
BRAIN RESEARCH, 2005, 1049 (01) :95-103
[2]
Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling [J].
Beck, H ;
Acker, T ;
Püschel, AW ;
Fujisawa, H ;
Carmeliet, P ;
Plate, KH .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (04) :339-350
[3]
Angiogenesis after cerebral ischemia [J].
Beck, Heike ;
Plate, Karl H. .
ACTA NEUROPATHOLOGICA, 2009, 117 (05) :481-496
[4]
Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil [J].
Bellomo, M ;
Adamo, EB ;
Deodato, B ;
Catania, MA ;
Mannucci, C ;
Marini, H ;
Marciano, MC ;
Marini, R ;
Sapienza, S ;
Giacca, M ;
Caputi, AP ;
Squadrito, F ;
Calapai, G .
PHARMACOLOGICAL RESEARCH, 2003, 48 (03) :309-317
[5]
Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis [J].
Brockington, A ;
Wharton, SB ;
Fernando, M ;
Gelsthorpe, CH ;
Baxter, L ;
Ince, PG ;
Lewis, CE ;
Shaw, PJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (01) :26-36
[6]
A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia [J].
Brusselmans, K ;
Bono, F ;
Collen, D ;
Herbert, JM ;
Carmeliet, P ;
Dewerchin, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3493-3499
[7]
Blood vessels and nerves: Common signals, pathways and diseases [J].
Carmeliet, P .
NATURE REVIEWS GENETICS, 2003, 4 (09) :710-720
[8]
Carmeliet P, 2000, Verh K Acad Geneeskd Belg, V62, P31
[9]
Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III [J].
Chen, H ;
Chedotal, A ;
He, ZG ;
Goodman, CS ;
TessierLavigne, M .
NEURON, 1997, 19 (03) :547-559
[10]
Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia [J].
Chi, Oak Z. ;
Hunter, Christine ;
Liu, Xia ;
Weiss, Harvey R. .
EXPERIMENTAL NEUROLOGY, 2007, 204 (01) :283-287